Skip to content
PatientMatchFind trials

Screener

Eligibility screening

Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

Sponsored by Hoffmann-La RocheStudy detailsClinicalTrials.gov

25 US sites in CA, FL, GA, IN +11

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.